Frontlight ResearchEarly access
Taking peopleNo phase
Tendyne European Experience Registry
Key facts
- Who runs it
- LMU Klinikum
- Where
- Austria, Belgium, France, Germany, Italy, Norway, Spain, Sweden, Switzerland, and United Kingdom30 sites in 10 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 15 Apr 2021
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Treatments tested
- Tendyne Mitral Valve System
- Record updated
- 24 May 2021
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients treated with the Tendyne Mitral Valve System for mitral valve disease in a commercial setting
- Patients providing written informed consent in compliance with the protocol, the ICH-GCP and all national legal and regulatory requirements
Who cannot take part
- Patients not providing written informed consent
This trial has no sites in United States.
It has sites in 10 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.
The group in the trial
- Tendyne
all patients treated with a Tendyne Mitral Valve System
Treatment: Tendyne Mitral Valve System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- TENDyne European expeRience Registry
- Publications
- Transapical Mitral Valve Replacement: 1-Year Results of the Real-World Tendyne European Experience Registry.JACC. Cardiovascular interventions, 2024
- Record updated
- 24 May 2021